Literature DB >> 7819900

Glomerulonephritis: diagnosis and treatment.

P D Mason1, C D Pusey.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 7819900      PMCID： PMC2541769          DOI： 10.1136/bmj.309.6968.1557

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  21 in total

1.  Idiopathic membranous nephropathy: the natural history of untreated patients.

Authors:  J V Donadio; V E Torres; J A Velosa; R D Wagoner; K E Holley; M Okamura; D M Ilstrup; C P Chu
Journal:  Kidney Int       Date:  1988-03       Impact factor: 10.612

2.  A standard nomenclature for structures of the kidney. The Renal Commission of the International Union of Physiological Sciences (IUPS).

Authors:  W Kriz; L Bankir
Journal:  Kidney Int       Date:  1988-01       Impact factor: 10.612

3.  Minimal change nephrotic syndrome and cyclophosphamide.

Authors:  R S Trompeter
Journal:  Arch Dis Child       Date:  1986-08       Impact factor: 3.791

4.  Steroid-dependent nephrotic syndrome in children: histopathology and relapses after cyclophosphamide treatment.

Authors:  N J Siegel; K M Gaudio; L S Krassner; B M McDonald; F P Anderson; M Kashgarian
Journal:  Kidney Int       Date:  1981-03       Impact factor: 10.612

5.  Adult-onset minimal change nephrotic syndrome: a long-term follow-up.

Authors:  F Nolasco; J S Cameron; E F Heywood; J Hicks; C Ogg; D G Williams
Journal:  Kidney Int       Date:  1986-06       Impact factor: 10.612

6.  The nephrotic syndrome in IgA glomerulonephritis: response to corticosteroid therapy.

Authors:  J Mustonen; A Pasternack; I Rantala
Journal:  Clin Nephrol       Date:  1983-10       Impact factor: 0.975

7.  Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs.

Authors:  H A Austin; J H Klippel; J E Balow; N G le Riche; A D Steinberg; P H Plotz; J L Decker
Journal:  N Engl J Med       Date:  1986-03-06       Impact factor: 91.245

8.  Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.

Authors:  C Ponticelli; P Zucchelli; E Imbasciati; L Cagnoli; C Pozzi; P Passerini; C Grassi; D Limido; S Pasquali; T Volpini
Journal:  N Engl J Med       Date:  1984-04-12       Impact factor: 91.245

9.  The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group.

Authors:  S Klahr; A S Levey; G J Beck; A W Caggiula; L Hunsicker; J W Kusek; G Striker
Journal:  N Engl J Med       Date:  1994-03-31       Impact factor: 91.245

10.  Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis. Regional Glomerulonephritis Registry Study.

Authors:  Y Pei; D Cattran; T Delmore; A Katz; A Lang; P Rance
Journal:  Am J Med       Date:  1987-05       Impact factor: 4.965
View more
  5 in total

Review 1.  Optimisation of cyclophosphamide therapy in systemic vasculitis.

Authors:  R Richmond; T W McMillan; R A Luqmani
Journal:  Clin Pharmacokinet       Date:  1998-01       Impact factor: 6.447

2.  Management of childhood nephrotic syndrome.

Authors:  G Smith
Journal:  BMJ       Date:  1995-02-25

3.  Kidney Diseases: The Age of Molecular Markers.

Authors:  Glaucia Luciano da Veiga; Beatriz da Costa Aguiar Alves; Matheus Moreira Perez; Joyce Regina Raimundo; Jéssica Freitas de Araújo Encinas; Neif Murad; Fernando Luiz Affonso Fonseca
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Post-streptococcal glomerulonephritis and uveitis--a case report.

Authors:  Michal Feldon; Lev Dorfman; Tsivia Tauber; Yair Morad; Tzvy Bistritzer; Michael Goldman
Journal:  Pediatr Nephrol       Date:  2010-06-02       Impact factor: 3.714

5.  Regulatory T cells require renal antigen recognition through the TCR to protect against injury in nephritis.

Authors:  Ya Wang; Yuanmin Wang; Yiping Wang; Guoping Zheng; Thian Kui Tan; Sora Lee; Jianlin Zhang; Geoff Yu Zhang; Min Hu; Changqi Wang; Qi Cao; Ye Zhao; Xin Maggie Wang; Stephen I Alexander; David C Harris
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.